We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.16B
AUM Growth
-$38.5M
Cap. Flow
-$16.1M
Cap. Flow %
-1.39%
Top 10 Hldgs %
4.12%
Holding
2,179
New
583
Increased
522
Reduced
502
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 16.3%
2 Technology 15.76%
3 Financials 13.46%
4 Industrials 12.71%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQT icon
1076
Arcutis Biotherapeutics
ARQT
$3.18B
$352K 0.03%
12,125
-21,567
-64% -$552K
AOSL icon
1077
Alpha and Omega Semiconductor
AOSL
$1.08B
$350K 0.03%
17,675
-18,506
-51% -$437K
EWTX icon
1078
Edgewise Therapeutics
EWTX
$4.73B
$350K 0.03%
14,085
-99,158
-88% -$1.99M
NCNO icon
1079
nCino
NCNO
$2.1B
$350K 0.03%
+13,659
New +$347K
SEAT icon
1080
Vivid Seats
SEAT
$85.4M
$350K 0.03%
+48,504
New +$477K
TALK icon
1081
Talkspace
TALK
$874M
$350K 0.03%
96,540
-162,677
-63% -$516K
UFCS icon
1082
United Fire Group
UFCS
$1.4B
$350K 0.03%
9,625
+2,667
+38% +$91.2K
CTMX icon
1083
CytomX Therapeutics
CTMX
$754M
$349K 0.03%
81,886
-454,088
-85% -$1.72M
ICUI icon
1084
ICU Medical
ICUI
$4.61B
$349K 0.03%
2,444
-734
-23% -$98.3K
SPXC icon
1085
SPX Corp
SPXC
$10.8B
$349K 0.03%
+1,744
New +$356K
PBE icon
1086
Invesco Biotechnology & Genome ETF
PBE
$353M
$348K 0.03%
+4,239
New +$328K
BFAM icon
1087
Bright Horizons
BFAM
$3.86B
$347K 0.03%
3,425
-19,396
-85% -$1.96M
ATRO icon
1088
Astronics
ATRO
$3.84B
$346K 0.03%
+7,662
New +$321K
EWY icon
1089
iShares MSCI South Korea ETF
EWY
$25.7B
$346K 0.03%
3,558
-1,457
-29% -$133K
LEU icon
1090
Centrus Energy
LEU
$3.82B
$346K 0.03%
+1,427
New +$431K
NIC icon
1091
Nicolet Bankshares
NIC
$3.62B
$345K 0.03%
+2,844
New +$359K
MFIN icon
1092
Medallion Financial
MFIN
$250M
$343K 0.03%
33,359
-11,428
-26% -$115K
AYI icon
1093
Acuity Brands
AYI
$10.8B
$342K 0.03%
949
-2,615
-73% -$945K
C icon
1094
Citigroup
C
$226B
$342K 0.03%
2,933
-107
-4% -$11.1K
HELE icon
1095
Helen of Troy
HELE
$693M
$342K 0.03%
+16,086
New +$328K
BHP icon
1096
BHP
BHP
$230B
$341K 0.03%
+5,654
New +$321K
BKSY icon
1097
BlackSky Technology
BKSY
$1.19B
$341K 0.03%
18,180
-5,766
-24% -$118K
BRZE icon
1098
Braze
BRZE
$2.99B
$340K 0.03%
+9,908
New +$294K
DKS icon
1099
Dick's Sporting Goods
DKS
$18.7B
$340K 0.03%
+1,718
New +$375K
HCAT icon
1100
Health Catalyst
HCAT
$128M
$340K 0.03%
+142,337
New +$389K

Similar funds

GSA Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, GSA Capital Partners held 2,179 positions worth $1.16B, down 3.2% from $1.2B the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

GSA Capital Partners's Q4 2025 filing shows 583 new, 522 increased, 502 reduced and 562 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M. The largest sale was Nuvation Bio, an estimated $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GSA Capital Partners's largest Q4 2025 buy was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M.
  • GSA Capital Partners added most to Remitly in Q4 2025, an estimated $4.91M increase.
  • GSA Capital Partners's biggest Q4 2025 reduction was Nuvation Bio, cutting an estimated $6.32M.
  • GSA Capital Partners fully exited Jefferies Financial Group in Q4 2025, selling an estimated $3.77M.
  • GSA Capital Partners's ten largest holdings make up 4.1% of its $1.16B portfolio in Q4 2025.
  • GSA Capital Partners opened 583 new positions and closed 562 in Q4 2025.
  • GSA Capital Partners's portfolio value fell 3.2% quarter-over-quarter to $1.16B.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.